AdaptHealth Corp. (NASDAQ:AHCO) CTO Albert A. Prast Sells 135,443 Shares

AdaptHealth Corp. (NASDAQ:AHCO) CTO Albert A. Prast sold 135,443 shares of AdaptHealth stock in a transaction that occurred on Monday, March 4th. The shares were sold at an average price of $10.41, for a total value of $1,409,961.63. Following the completion of the transaction, the chief technology officer now owns 181,083 shares of the company’s stock, valued at $1,885,074.03. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

AdaptHealth Stock Performance

Shares of AHCO opened at $11.48 on Friday. AdaptHealth Corp. has a 52-week low of $6.37 and a 52-week high of $11.90. The firm has a market capitalization of $1.53 billion, a PE ratio of -2.18, a P/E/G ratio of 0.77 and a beta of 1.10. The firm has a 50-day moving average price of $10.47 and a 200 day moving average price of $10.25. The company has a quick ratio of 0.94, a current ratio of 1.15 and a debt-to-equity ratio of 1.38.

AdaptHealth (NASDAQ:AHCO) last issued its quarterly earnings results on Tuesday, August 6th. The company reported $0.13 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.19 by ($0.06). The firm had revenue of $805.98 million for the quarter, compared to analyst estimates of $802.62 million. AdaptHealth had a negative net margin of 21.20% and a positive return on equity of 9.58%. The firm’s revenue for the quarter was up 1.6% compared to the same quarter last year. During the same quarter last year, the business posted $0.16 earnings per share. On average, sell-side analysts anticipate that AdaptHealth Corp. will post 0.84 earnings per share for the current fiscal year.

Analyst Ratings Changes

AHCO has been the topic of several recent research reports. Truist Financial reissued a “buy” rating and issued a $13.00 price target on shares of AdaptHealth in a report on Wednesday, May 15th. Royal Bank of Canada reiterated an “outperform” rating and issued a $13.00 target price on shares of AdaptHealth in a research note on Monday, August 12th. One research analyst has rated the stock with a sell rating, one has assigned a hold rating and three have issued a buy rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus target price of $10.70.

Institutional Investors Weigh In On AdaptHealth

A number of institutional investors and hedge funds have recently bought and sold shares of AHCO. Mackenzie Financial Corp raised its holdings in shares of AdaptHealth by 48.6% in the 2nd quarter. Mackenzie Financial Corp now owns 34,489 shares of the company’s stock worth $345,000 after purchasing an additional 11,280 shares in the last quarter. The Manufacturers Life Insurance Company increased its holdings in shares of AdaptHealth by 8.1% in the second quarter. The Manufacturers Life Insurance Company now owns 39,440 shares of the company’s stock valued at $394,000 after buying an additional 2,959 shares in the last quarter. MBB Public Markets I LLC bought a new position in shares of AdaptHealth in the second quarter valued at $142,000. Dark Forest Capital Management LP acquired a new stake in shares of AdaptHealth during the 2nd quarter valued at $384,000. Finally, Caxton Associates LP bought a new stake in shares of AdaptHealth during the 2nd quarter worth $383,000. 82.67% of the stock is owned by institutional investors and hedge funds.

About AdaptHealth

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.